Mansfield Bio-Incubator's Advisory Board members represent a group of healthcare and life-sciences professionals from diverse specialties who both advise the Leadership Team and are available as resources to Incubator companies.
Shelley Amster
Shelley is a Founder and Principal of ShelleyCO, LLC, a life science business development consulting firm. Shelley has worked in the life science and health industries for more than 45 years beginning clinical & research in the field of fertility, Andrology, IVF, male & female reproductive health, efforts that she remains front & center today. Shelley recently launched with her partner 3Daughters, a revolutionary LARC IUD company. Shelley advisor or board member on several emerging life science companies providing expertise in business development and as a scientific advisor. Shelley is also a recognized leader in conference production developing annual a few high quality life science programs creating interactive dialogue on cutting edge and most important topics while utilizing her well-connect network of industry leaders, KOLs, members of the investment community, entrepreneurs & innovator. Shelley remains top of her game and is an active mentor and role model for the entrepreneurs and scientists of tomorrow.
Eugene Buff, MD, PHD
Dr. Eugene Buff is a Registered Technology Transfer Professional (RTTP) and Certified Licensing Professional (CLP) with over twenty years of combined scientific, consulting and management experience. He has substantial expertise in a wide variety of industries, including but not limited to healthcare, biotechnology, medical devices, consumer products, materials and chemical manufacturing.
Dr. Buff is a Founder and President of Primary Care Innovation Consulting (PCIC), a new type of innovation management and business development firm supporting companies’ growth through open innovation. PCIC provides technology strategy consulting for both large and small companies globally and has unique access to cutting edge innovation at universities, incubators and accelerators worldwide. Its signature product, Innovation Navigator™ offers comprehensive business development support by combining known theories (such as Lean Start Up, “Jobs-To-Be-Done” and Disruptive Innovation) with years of successful consulting practices. Dr. Buff also designs and delivers variety of training and educational programs on innovation, entrepreneurship, technology scouting and technology commercialization.
Dr. Buff earned his Master degree in Biochemistry as well as his Medical Doctor degree from Russian State Medical University. He is also a Ph.D. in Genetics and is a coauthor of 14 papers in peer reviewed international journals. Eugene is an active member of the Licensing and Technology Transfer community and serves on several committees and task forces at AUTM and LES. He is a member on many consulting and professional network organizations and often mentors and presents on issues of Entrepreneurship, Intellectual Property, Innovation and Technology Transfer both in US and internationally.
Imran Chowdhury, phD
Imran Chowdhury is Dean of the Ketner School of Business at Catawba College in Salisbury, North Carolina. Dr. Chowdhury’s research and teaching examines how companies work to develop ecosystems for entrepreneurs with a social impact focus, and how they balance economic and social demands simultaneously. His engagement with the business and academic communities builds on both his academic expertise and his industry experience, including working within the public health sector in Malawi, at a leading entrepreneurial biotechnology company in New York and in Uganda, and serving on briefing panels for Members of Congress on entrepreneurship-related issues.
Dr. Chowdhury graduated from Stuyvesant High School and earned his undergraduate degree from Hunter College, where he was elected to Phi Beta Kappa. He completed graduate studies in France, obtaining a master’s degree at L’Institut européen d’administration des affaires (INSEAD), and a Ph.D. from L’École supérieure des sciences économiques et commerciales (ESSEC Business School).
Pabel Delgado
Pabel Delgado is a US-Japan biopharma professional and Nutrition Medicine entrepreneur and clinical professor of social entrepreneurship with diverse academic and professional experiences. These include roles researching neural stem cells and other seed biotechnologies at The Rockefeller University, Weill-Cornell School of Medicine, the University of California Irvine and RIKEN Center for Developmental Biology of Japan's national laboratories, as well as strategic pharmaceutical industry roles at Alfresa Pharma Corporation and Shionogi & Co., Ltd., where he made material contributions to strategy development and alliance management. As an entrepreneur, Pabel's journey led to the founding of Asterism Healthcare, a B2B nutraceuticals CDMO, in addition to Et Alia Health & Medical Corporation, a vertically integrated B2B2C nutraceuticals startup. Most recently, Pabel has served as a Professor of Social Entrepreneurship at Wheaton College Massachusetts, where he developed an innovative experiential learning course with an interdisciplinary approach to examining real-world conditions, resources, components, processes, and rationales within biotechnology ventures and social impact organizations. Alongside these vocations, Pabel served as Executive Committee Member & Chairman of the Kansai Business Programs Committee at the American Chamber of Commerce in Japan (ACCJ) before founding The International Chamber of Innovation, Commerce and Enterprise (ICICE) and initiating the Sector Six (S6IX) International Accelerator Program in Japan.
Mark Norige, MBA
Mark Norige is the Principal and CEO of the Board Forum, a successful CEO peer advisory firm and Chief Executive Manager of CHP LLC, an early stage medicinal products company. Mark brings 30 plus years of business leadership experience helping small to mid-size companies grow revenue and profits by conducting analysis of their business and guides them to develop strategies and execution plans to achieve their desired results. He is a university adjunct professor at Worcester Polytechnic Institute, Brown University and Dean College. He earned his B.S. Engineering from University of Massachusetts and a MBA from Babson College.
Prior to the Board Forum, Mark worked for both early stage and Fortune 300 global companies including Texas Instruments, Waters, Millipore, and Harvard Bioscience along with several early stage investor backed firms in a variety of leadership roles in operations, product development, quality, business development and executive management. His successes include; product development with over twenty new product launches; business development with a dozen acquisitions and license deals completed and multiple successful turnarounds. He is most passionate applying his combined work and teaching experience to assist early stage businesses.
JULIA Rashba-STEP, PhD
Dr. Julia Rashba-Step is a senior pharmaceutical professional with an extensive background in nanotechnology, biotechnology and pharmaceutical industries. Julia has experience working at both small companies (Epic Therapeutics) and global pharmaceutical companies including Baxter, Wyeth and Pfizer, where she held positions of growing responsibilities, leading formulation, packaging and delivery groups.
Julia's most recent position was a Vice President of Research & Development and Alliance Management at Phosphorex where she worked closely with Pharma and Biotech partners to help advance cutting edge innovative technologies into the critical pre-clinical and clinical stage programs.
Dr Rashba-Step has multiple scientific publications in the field, as well as patents and and serves on multiple Advisory Boards.
Julia is passionate about mentoring and coaching as the way of giving back to the community. Julia was a Co-chair of Women’s leadership Network at Pfizer, served as a Mentor for HBA (Healthcare Business Women’s association. Julia received a Life coach certification with the focus on career development coaching. Julia served as a mentor for MassBio Connect program, helping biotech startups to develop their business cases.
ADVISORY BOARD EMERITUS: Susan Hanlon Daudelin, MBA
Susan Hanlon Daudelin is a mother and biotechnology entrepreneur. Her expertise is in intellectual property, the convergence of life science sector capabilities and the matrixed nature of the Massachusetts life science ecosystem.
Always working to advance promising biotechnology solutions to the market and to those who need them most, Susan collaborates with those who share her passion for using science to solve big, important problems. This is what drives her.
At the Mansfield Bio-Incubator, she provides strategic advice and has been on the incubator’s advisory board since 2018. Susan authored the successful $4M MLSC matching grant ($2M MLSC, $2M private match) in 2019 which allowed for more than doubling the existing footprint, including the buildout of much needed private laboratories. The expansion was completed in 2022.
Her professional roles in biotechnology include founding an advisory company, Nefertiti Biotech Advisory, as well as co-founding and running a bluetech biotechnology company as CEO. This international biotechnology startup company created synthetic biology solutions in farmed salmon. She encourages all women entrepreneurs in biotechnology.
Susan holds a BA from Williams College in Williamstown, Massachusetts where she double majored in biology and English. Additionally, she holds an MBA in international management.
In MemOry OF Judy Isaacson, MS
Judy brings over 30 years of experience in medical marketing, communications, investor and public relations. Her specialty is working with small- to medium-sized businesses (SMBs), and startups, increasing overall brand awareness and market share.
Judy is currently Executive Consultant at Vital Now!, an independent consultancy where she helps medical organizations in the areas of corporate branding, medical education, and medical communications.
Prior to Vital Now!, Judy was Vice President of Marketing at Medical Support Systems, a Database Publishing Group company, where she worked extensively with numerous professional medical associations and their pharmaceutical sponsors in producing continuing medical education for a various medical disciplines, namely, hematology, gastroenterology, cardiology, ophthalmology, to name a few.
Prior to Medical Support Systems, Judy was President of Effective Corporate Communications Inc., a boutique full-service marketing communications/public relations agency where she independently created a business model for developing corporate identities which led to follow-on programs in collateral development, advertising, lead generation, and web development, and public relations programs.
Prior to Effective Corporate Communications Inc., Judy was Director of Marketing and Corporate Communications at AST Products, Inc. in Billerica, MA. Prior to AST Products, Inc., Judy was Manager of Marketing and Investor Relations at Spire Corporation.
Judy is a former adjunct lecturer at several Boston-area colleges. Judy received her Bachelor of Arts degree from Emmanuel College and her Master of Science degree from Simmons College in Communications Management. Her graduate thesis addressed “The Importance of a Corporate Image.”